{"id": "1387729626055671809", "creation": 1619695500.0, "user_id": "2570920968", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "Forget the competition, Sanofi still plans to usher its COVID-19 shot across the finish line! The French drugmaker and its partner GlaxoSmithKline expect phase 2 data on their recombinant protein-based shot in a few weeks! $SNY $GSK #COVID19 #vaccine \nhttps://t.co/TvbIJEK8bk", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}